These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25744459)
21. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil. Higashi H; Watanabe N; Tamura R; Taguchi M Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012 [TBL] [Abstract][Full Text] [Related]
22. Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor. Tian QQ; Zhu YT; Diao XX; Zhang XL; Xu YC; Jiang XR; Shen JS; Wang Z; Zhong DF Acta Pharmacol Sin; 2021 Mar; 42(3):482-490. PubMed ID: 32581257 [TBL] [Abstract][Full Text] [Related]
23. Identification of CYP3A7 for glyburide metabolism in human fetal livers. Shuster DL; Risler LJ; Prasad B; Calamia JC; Voellinger JL; Kelly EJ; Unadkat JD; Hebert MF; Shen DD; Thummel KE; Mao Q Biochem Pharmacol; 2014 Dec; 92(4):690-700. PubMed ID: 25450675 [TBL] [Abstract][Full Text] [Related]
24. Interaction of lapatinib with cytochrome P450 3A5. Chan EC; New LS; Chua TB; Yap CW; Ho HK; Nelson SD Drug Metab Dispos; 2012 Jul; 40(7):1414-22. PubMed ID: 22511346 [TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib. Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182 [TBL] [Abstract][Full Text] [Related]
26. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study. Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640 [TBL] [Abstract][Full Text] [Related]
27. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306 [TBL] [Abstract][Full Text] [Related]
28. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Kharasch ED; Hoffer C; Whittington D; Sheffels P Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986 [TBL] [Abstract][Full Text] [Related]
29. Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity. Chen YJ; Zhang J; Zhu PP; Tan XW; Lin QH; Wang WX; Yin SS; Gao LZ; Su MM; Liu CX; Xu L; Jia W; Sevrioukova IF; Lan K Drug Metab Dispos; 2019 Jun; 47(6):574-581. PubMed ID: 30918015 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model. Walton RB; Reed LC; Estrada SM; Schmiedecke SS; Villazana-Kretzer DL; Napolitano PG; Ieronimakis N Hypertension; 2018 Jul; 72(1):167-176. PubMed ID: 29735634 [TBL] [Abstract][Full Text] [Related]
31. Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants. Salerno SN; Edginton A; Gerhart JG; Laughon MM; Ambalavanan N; Sokol GM; Hornik CD; Stewart D; Mills M; Martz K; Gonzalez D; Clin Pharmacol Ther; 2021 Jan; 109(1):253-262. PubMed ID: 32691891 [TBL] [Abstract][Full Text] [Related]
32. Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans. Hohmann N; Reinhard R; Schnaidt S; Witt L; Carls A; Burhenne J; Mikus G; Haefeli WE J Antimicrob Chemother; 2016 Aug; 71(8):2241-7. PubMed ID: 27141088 [TBL] [Abstract][Full Text] [Related]
33. A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5. Wu JJ; Cao YF; Feng L; He YQ; Hong JY; Dou TY; Wang P; Hao DC; Ge GB; Yang L J Med Chem; 2017 May; 60(9):3804-3813. PubMed ID: 28441491 [TBL] [Abstract][Full Text] [Related]
34. Variation in Expression of Cytochrome P450 3A Isoforms and Toxicological Effects: Endo- and Exogenous Substances as Regulatory Factors and Substrates. Fujino C; Sanoh S; Katsura T Biol Pharm Bull; 2021; 44(11):1617-1634. PubMed ID: 34719640 [TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450-mediated metabolic interactions between donepezil and tadalafil in human liver microsomes. Yu J; Ryu JH; Chi YH; Paik SH; Kim SK Toxicol In Vitro; 2024 Oct; 100():105922. PubMed ID: 39173683 [TBL] [Abstract][Full Text] [Related]
36. CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches. Davis MA; Barnette DA; Flynn NR; Pidugu AS; Swamidass SJ; Boysen G; Miller GP Chem Res Toxicol; 2019 Jun; 32(6):1151-1164. PubMed ID: 30925039 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7. Godamudunage MP; Grech AM; Scott EE Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575 [TBL] [Abstract][Full Text] [Related]
38. Heterotropic cooperativity in oxidation mediated by cytochrome p450. Niwa T; Murayama N; Yamazaki H Curr Drug Metab; 2008 Jun; 9(5):453-62. PubMed ID: 18537580 [TBL] [Abstract][Full Text] [Related]
39. Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice. Nishimura T; Ishii M; Tanaka H; Noguchi S; Ikeda T; Tomi M J Pharm Sci; 2024 Feb; 113(2):486-492. PubMed ID: 37981232 [TBL] [Abstract][Full Text] [Related]